Work

Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Bone and Mineral Research

DOI: 10.1359/jbmr.091035

Authors: Henry G Bone, Michael R McClung, Christian Roux, Robert R Recker, John A Eisman, Nadia Verbruggen, Carolyn M Hustad, Carolyn DaSilva, Arthur C Santora, B Avery Ince

Institutions: Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Université Paris Descartes, Creighton University, Garvan Institute of Medical Research, UNSW Sydney, MSD (Belgium), Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Bone health and osteoporosis research

Subfield: Orthopedics and Sports Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Procter and Gamble

OpenAlex ID: W2028917977

FWCI: 38.53

Cites: 23

Cited by: 334

Related to: 10